Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc MYCOF


Primary Symbol: C.MYCO

Healthcare Advertising Agencies
Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Mydecine Innovations Group Inc > Has anyone checked the news today from MYCO
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(90)
•••
Comment by Ryezensum911on Jan 14, 2021 10:40am
184 Views
Post# 32293703

RE:RE:RE:RE:RE:RE:RE:Has anyone checked the news today from MYCO

RE:RE:RE:RE:RE:RE:RE:Has anyone checked the news today from MYCOYes I do own this stock at the moment, but as I stated, I will sell today, and watch from the sidelines.  I was extremely optimistic here until I read the News this morning. Im just being honest. If I'm wrong, then good for you, and anyone else here that isn't afraid of the boogie man that is Cannacord. I always want the best for legitimate start up companies, and I very much despise short selling. Hence the distaste and disappointment for me with todays news. Thats just me. Do your own DD, and follow your own visceral instincts. GLTA.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities